These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27390608)

  • 21. Pancreatic cancer: progress in cancer therapy.
    Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 Sep; 352(9132):930-42. PubMed ID: 9752815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New developments in the treatment of pancreatic cancer].
    Marsman HA; Besselink MG
    Ned Tijdschr Geneeskd; 2016; 160():D538. PubMed ID: 27758723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
    He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
    BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies.
    Chiorean EG; Coveler AL
    Drug Des Devel Ther; 2015; 9():3529-45. PubMed ID: 26185420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy.
    Sarantis P; Koustas E; Papadimitropoulou A; Papavassiliou AG; Karamouzis MV
    World J Gastrointest Oncol; 2020 Feb; 12(2):173-181. PubMed ID: 32104548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation.
    Paiella S; De Pastena M; D'Onofrio M; Crinò SF; Pan TL; De Robertis R; Elio G; Martone E; Bassi C; Salvia R
    Transl Gastroenterol Hepatol; 2018; 3():80. PubMed ID: 30505967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oxaliplatin in gastro-intestinal tract cancer except colorectal cancer].
    Louafi S; Mansourbakht T; Bonyhay L; Taïeb J
    Bull Cancer; 2006 Feb; 93 Suppl 1():S23-33. PubMed ID: 16483942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer.
    Su TS; Liang P; Lu HZ; Liang JN; Liu JM; Zhou Y; Gao YC; Tang MY
    World J Gastroenterol; 2015 Jul; 21(26):8156-62. PubMed ID: 26185389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic treatment of advanced pancreatic cancer.
    Heinemann V; Haas M; Boeck S
    Cancer Treat Rev; 2012 Nov; 38(7):843-53. PubMed ID: 22226241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.
    Zhu L; Staley C; Kooby D; El-Rays B; Mao H; Yang L
    Cancer Lett; 2017 Mar; 388():139-148. PubMed ID: 27916607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radical procedures in patients with pancreatic cancer--impact on prolongation and quality of life].
    Ryska M
    Rozhl Chir; 2010 Dec; 89(12):725-30. PubMed ID: 21404511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
    Stevens R; Macbeth F; Toy E; Coles B; Lester JF
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD002143. PubMed ID: 25586198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy, Radiotherapy, and Hyperthermia: A Combined Therapeutic Approach in Pancreatic Cancer Treatment.
    Mahmood J; Shukla HD; Soman S; Samanta S; Singh P; Kamlapurkar S; Saeed A; Amin NP; Vujaskovic Z
    Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30486519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of Stereotactic Body Radiation Therapy into the Multidisciplinary Management of Pancreatic Cancer.
    Rosati LM; Kumar R; Herman JM
    Semin Radiat Oncol; 2017 Jul; 27(3):256-267. PubMed ID: 28577833
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.